Metropolitan Life Insurance Company (MetLife)’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,703	Closed	-$153K	–	2608
2015 Q4	$153K	Hold	14,703	–	–	﹤0.01%	2424
2015 Q3	$272K	Sell	14,703 -1,509	-9%	-$29.1K	﹤0.01%	2052
2015 Q2	$315K	Buy	16,212 +776	+5%	+$13.7K	﹤0.01%	2084
2015 Q1	$271K	Hold	15,436	–	–	﹤0.01%	1892
2014 Q4	$247K	Hold	15,436	–	–	﹤0.01%	2259
2014 Q3	$194K	Hold	15,436	–	–	﹤0.01%	2389
2014 Q2	$241K	Hold	15,436	–	–	﹤0.01%	2377
2014 Q1	$203K	Hold	15,436	–	–	﹤0.01%	2452
2013 Q4	$248K	Hold	15,436	–	–	﹤0.01%	2318
2013 Q3	$165K	Hold	15,436	–	–	﹤0.01%	2561
2013 Q2	$155K	Buy	+15,436	New	+$162K	﹤0.01%	2530

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OSIR Position: Q1 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2016, closing a stake of 14,703 shares — an estimated $153K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OSIR in Q2 2013 and held it in 11 quarters. The position peaked at $315K in Q2 2015. 80 funds tracked by Wall St. Rank hold OSIR as of Q1 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 14,703 Osiris Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $153K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
Metropolitan Life Insurance Company (MetLife)'s Osiris Therapeutics, Inc. Common Stock position peaked at $315K in Q2 2015.
80 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2016, filed 16 May 2016.